Page 128 - Genomic Medicine in Emerging Economies
P. 128

References   117




           clinicians and regulatory institutions, in order to facilitate the use of phar-
           macogenetics tests (Quinones et al., 2014).
           As reviewed in previous sections, there are several diseases of high epidemio-
           logical impact that have been relatively understudied in Latin American coun-
           tries (e.g., autism, MDD, migraine, multiple sclerosis, epilepsies, and alcohol
           and drug abuse). A focus on the large burden of these disorders might benefit
           from the possibility that public agencies would provide available funds for its
           mitigation (Forero et al., 2014).


           Acknowledgments
           Research in the Laboratory of Neuropsychiatric Genetics (Universidad Antonio Nariño) has been
           supported by grants from VCTI-UAN and Colciencias (to DAF). YG-G is supported by a PhD fel-
           lowship from Centro de Estudios Interdisciplinarios Básicos y Aplicados CEIBA (Rodolfo Llinás
           Program). We thank Leon Ruiter Lopez for his help for the generation of Fig. 6.1.


           References

           Adhikari, K., Mendoza-Revilla, J., Chacon-Duque, J.C., Fuentes-Guajardo, M., Ruiz-Linares,
              A., 2016. Admixture in Latin America. Curr. Opin. Genet. Dev. 41, 106–114. doi: 10.1016/j.
              gde.2016.09.003.
           Agudelo, J.A., Gálvez, J.M., Fonseca, D.J., Mateus, H.E., Talero-Gutierrez, C., Velez-Van-Meerbeke,
              A., 2015. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes
              of  attention  deficit/hyperactivity  disorder.  Neurologia  30  (3),  137–143.  doi: 10.1016/j.
              nrl.2013.12.005.
           Akutagava-Martins, G.C., Salatino-Oliveira, A., Bruxel, E.M., Genro, J.P., Mota, N.R.,
                Polanczyk, G.V., Hutz, M.H., 2014a. Lack of association between the GRM7 gene and at-
              tention deficit hyperactivity disorder. Psychiatr. Genet. 24 (6), 281–282. doi: 10.1097/
              ypg.0000000000000059.
           Akutagava-Martins, G.C., Salatino-Oliveira, A., Genro, J.P., Contini, V., Polanczyk, G., Zeni, C.,
              Hutz, M.H., 2014b. Glutamatergic copy number variants and their role in attention-deficit/
              hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 165B (6), 502–509. doi:
              10.1002/ajmg.b.32253.
           Akutagava-Martins, G.C., Salatino-Oliveira, A., Kieling, C., Genro, J.P., Polanczyk, G.V., Anselmi,
              L., Hutz, M.H., 2016. COMT and DAT1 genes are associated with hyperactivity and inattention
              traits in the 1993 Pelotas Birth Cohort: evidence of sex-specific combined effect. J. Psychiatry
              Neurosci. 41 (6), 405–412. doi: 10.1503/jpn.150270.
           Alvim-Soares, A., Miranda, D., Campos, S.B., Figueira, P., Romano-Silva, M.A., Correa, H., 2013.
              Postpartum depression symptoms associated with Val158Met COMT polymorphism. Arch.
              Womens Ment. Health 16 (4), 339–340. doi: 10.1007/s00737-013-0349-8.
           Arboleda, G.H., Yunis, J.J., Pardo, R., Gomez, C.M., Hedmont, D., Arango, G., Arboleda, H., 2001.
              Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimer’s disease.
              Neurosci. Lett. 305 (2), 135–138.
           Arcos-Burgos, M., Jain, M., Acosta, M.T., Shively, S., Stanescu, H., Wallis, D., Muenke, M., 2010.
              A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and
   123   124   125   126   127   128   129   130   131   132   133